Continuous Bioprocessing Global Market Report 2026

Continuous bioprocessing is a manufacturing method in which biological products are produced through a continuous flow of materials across integrated upstream and downstream processing operations. It enables uninterrupted cultivation, separation, purification, and product recovery within a unified production process. This approach enhances manufacturing efficiency, ensures consistent product quality, and lowers processing time and operational costs in the biopharmaceutical and biotechnology industries.

The primary products of continuous bioprocessing include filtration systems and consumables, chromatography systems and consumables, cell culture media, buffers, and reagents, incubators and shakers, bioreactors, centrifuges, sterilizers, and other instruments and consumables. Filtration systems and consumables refer to equipment and materials used for the continuous separation and purification of biological products during manufacturing processes. These products are used across process types including upstream processes and downstream processes and are available for large-scale, mid-scale, and small-scale operations. The various applications include vaccine production, antibody production, cell and gene therapy, enzyme production, recombinant protein production, and others and they are utilized by end users including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, and academic research institutes and laboratories.

Tariffs are influencing the continuous bioprocessing market by increasing the cost of imported bioreactors, filtration systems, chromatography equipment, sensors, reagents, and precision manufacturing components required for integrated bioprocess operations. This is affecting manufacturing costs and operational efficiency across vaccine production, antibody production, recombinant protein production, and cell and gene therapy applications. Product segments such as bioreactors, filtration systems and consumables, and chromatography systems and consumables are most affected due to their dependence on specialized equipment and globally sourced materials. Regions with high dependence on imported bioprocessing technologies, particularly North America, Europe, and Asia-Pacific, are experiencing stronger supply chain and cost pressures. However, tariffs are also encouraging domestic manufacturing expansion, supplier diversification, and increased investment in local biotechnology production ecosystems, improving long-term market resilience.

The continuous bioprocessing market size has grown exponentially in recent years. It will grow from $0.38 billion in 2025 to $0.46 billion in 2026 at a compound annual growth rate (CAGR) of 21.9%. The growth in the historic period can be attributed to growth in biologics manufacturing demand, increasing adoption of biopharmaceutical production technologies, expansion of monoclonal antibody production, rising investments in biotechnology research activities, increasing focus on reducing manufacturing costs.

The continuous bioprocessing market size is expected to see exponential growth in the next few years. It will grow to $1.01 billion in 2030 at a compound annual growth rate (CAGR) of 21.5%. The growth in the forecast period can be attributed to growing demand for cell and gene therapies, increasing investments in advanced bioprocessing facilities, rising demand for scalable manufacturing platforms, increasing adoption of automated process monitoring systems, expansion of personalized medicine development. Major trends in the forecast period include increasing adoption of single-use processing systems, growing preference for integrated upstream and downstream workflows, rising demand for high-yield biomanufacturing processes, increasing focus on process consistency and quality control, expansion of continuous production methods for biologics manufacturing.

The increasing demand for personalized medicine is expected to propel the growth of the continuous bioprocessing market going forward. Personalized medicine refers to a medical approach that customizes treatment based on an individual's genetic profile, biomarkers, and disease characteristics to improve therapeutic effectiveness and patient outcomes. The increasing demand for personalized medicine is driven by the growing adoption of targeted and precision therapies tailored to individual patient profiles. Continuous bioprocessing supports personalized medicine by enabling flexible, scalable, and efficient production of small-batch, high-value biologics and advanced therapies while improving product consistency and reducing manufacturing timelines. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, representing a significant increase from the six approved in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the continuous bioprocessing market.

Leading companies operating in the continuous bioprocessing market are focusing on developing advanced single-use manufacturing solutions, such as integrated antibody drug conjugate processing platforms, to improve production efficiency, enhance contamination control, and support flexible biologics manufacturing. Integrated antibody drug conjugate processing platforms refer to specialized single-use systems designed to streamline the manufacturing, handling, and purification of antibody drug conjugates in biopharmaceutical production environments. For example, in September 2024, Merck KGaA, a Germany-based science and technology company, launched the Mobius ADC Reactor, a single-use manufacturing solution designed to improve the safe and efficient production of antibody drug conjugates. The system supports high-potency bioprocessing applications by offering enhanced containment, disposable fluid paths, and flexible scalability, helping biopharmaceutical manufacturers optimize production workflows and reduce cross-contamination risks during continuous processing operations.

In August 2024, Merck KGaA, a Germany-based science and technology company, acquired Mirus Bio for $600 million. Through this acquisition, Merck aimed to strengthen its viral vector bioprocessing capabilities and expand its integrated solutions portfolio for cell and gene therapy manufacturing. The acquisition also enhanced Merck's upstream bioprocessing offerings by incorporating Mirus Bio's advanced transfection technologies, which are widely used in viral vector production processes. Mirus Bio is a US-based biotechnology company specializing in transfection reagents and gene delivery technologies used in viral vector-based cell and gene therapies.

Major companies operating in the continuous bioprocessing market are Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Sartorius AG; Lonza Group AG; Repligen Corporation; 3M Company; Fujifilm Corporation; Asahi Kasei Corporation; Corning Incorporated; Entegris Inc.; Getinge AB; Eppendorf SE; Bio-Rad Laboratories; Meissner Filtration Products Inc.; Shimadzu Corporation; Hamilton Company; Adolf Kuhner AG; PBS Biotech Inc.; Esco Lifesciences Group; Bio-Techne; SATAKE MultiMix Corporation

North America was the largest region in the continuous bioprocessing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous bioprocessing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the continuous bioprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The continuous bioprocessing market includes revenues earned by entities by providing services such as continuous cell culture processing, process optimization, integrated biomanufacturing support, automation and monitoring solutions, and contract manufacturing for biologics production. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The continuous bioprocessing market also includes sales of bioprocess skids, nutrient feed systems, aseptic transfer components, disposable bioprocess containers, inline dilution systems, microbial fermentation equipment, flow distribution manifolds, and integrated fluid handling systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The continuous bioprocessing market research report is one of a series of new reports from The Business Research Company that provides continuous bioprocessing market statistics, including continuous bioprocessing industry global market size, regional shares, competitors with a continuous bioprocessing market share, detailed continuous bioprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the continuous bioprocessing industry. This continuous bioprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Continuous Bioprocessing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses continuous bioprocessing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous bioprocessing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The continuous bioprocessing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Filtration Systems And Consumables; Chromatography Systems And Consumables; Cell Culture Media, Buffers, And Reagents; Incubators And Shakers; Bioreactors; Centrifuges; Sterilizers; Other Instruments And Consumables
• 2) By Process Type: Upstream Processes; Downstream Processes
• 3) By Scale: Large Scale; Mid Scale; Small Scale
• 4) By Application: Vaccine Production; Antibody Production; Cell And Gene Therapy; Enzyme Production; Recombinant Protein Production; Other Applications
• 5) By End User: Pharmaceutical And Biotechnology Companies; Contract Development And Manufacturing Organizations; Academic Research Institutes And Laboratories
• Subsegments:
• 1) By Filtration Systems And Consumables: Membrane Filtration Systems; Depth Filtration Systems; Tangential Flow Filtration Systems; Cartridge Filters; Filter Cartridges; Disposable Filtration Assemblies; Filtration Membranes; Filter Holders And Housings
• 2) By Chromatography Systems And Consumables: Liquid Chromatography Systems; Continuous Chromatography Systems; Chromatography Columns; Chromatography Resins; Buffer Preparation Systems; Fraction Collectors; Chromatography Tubing And Connectors; Disposable Chromatography Components
• 3) By Cell Culture Media, Buffers, And Reagents: Serum Free Media; Chemically Defined Media; Cell Culture Supplements; Buffer Solutions; Growth Factors; Cell Dissociation Reagents; Process Reagents; Nutrient Feed Solutions
• 4) By Incubators And Shakers: Carbon Dioxide Incubators; Refrigerated Incubators; Orbital Shakers; Incubator Shakers; Temperature Controlled Shakers; Benchtop Incubators; Floor Standing Incubators; Microplate Shakers
• 5) By Bioreactors: Single Use Bioreactors; Stainless Steel Bioreactors; Perfusion Bioreactors; Stirred Tank Bioreactors; Airlift Bioreactors; Packed Bed Bioreactors; Bubble Column Bioreactors; Wave Induced Bioreactors
• 6) By Centrifuges: Laboratory Centrifuges; Industrial Centrifuges; Continuous Flow Centrifuges; Ultracentrifuges; Refrigerated Centrifuges; Benchtop Centrifuges; Floor Standing Centrifuges; Disc Stack Centrifuges
• 7) By Sterilizers: Steam Sterilizers; Dry Heat Sterilizers; Chemical Sterilizers; Radiation Sterilizers; Filtration Sterilizers; Laboratory Sterilizers; Industrial Sterilizers; Automated Sterilization Systems
• 8) By Other Instruments And Consumables: Sensors And Probes; Sampling Devices; Tubing And Connectors; Fluid Transfer Systems; Disposable Bags And Containers; Process Monitoring Instruments
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Sartorius AG; Lonza Group AG; Repligen Corporation; 3M Company; Fujifilm Corporation; Asahi Kasei Corporation; Corning Incorporated; Entegris Inc.; Getinge AB; Eppendorf SE; Bio-Rad Laboratories; Meissner Filtration Products Inc.; Shimadzu Corporation; Hamilton Company; Adolf Kuhner AG; PBS Biotech Inc.; Esco Lifesciences Group; Bio-Techne; SATAKE MultiMix Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.